Israel targets Teva over MS drug royalties
The state of Israel has sued Teva Pharmaceuticals for $100 million over alleged unpaid royalties relating to its multiple sclerosis drug, Copaxone.
Queen’s speech trails gene-editing innovation bill
The UK government will implement the Genetic Technology Bill which promises to “remove unnecessary barriers” inherited from the European Union to bolster gene-editing technology.
L’Oreal’s anti-wrinkle cosmetics infringe, claims GlycoBioSciences
Canadian pharmaceutical company GlycoBioSciences has sued cosmetics giant L’Oreal, alleging that the French company’s anti-wrinkle products containing hyaluronic acid infringe two patents.
Moderna aims to offset COVID vaccine lawsuit to US govt
Moderna has rejected claims that its COVID-19 vaccine violates the patent rights of two biopharma companies, arguing that its contract with the US federal government has conferred immunity.
BGI wins $333m in DNA patent suit with Illumina
Illumina has been ordered to pay more than $333 million to Chinese sequencing company MGI—a subsidiary of BGI Group formally known as Complete Genomics—following a jury ruling that Illumina infringed two of its DNA-sequencing patents.
Harvard, 10x say Vizgen infringes genomics patents
Harvard College and 10x Genomics have sued Vizgen, claiming that the Massachusetts-based biotech rival infringes five patents covering molecular analysis methods.
WTO reveals draft of COVID-19 IP waiver
A proposal for the COVID-19 vaccine waiver has been prepared for approval by the wider members of the World Trade Organisation.
English High Court denies Jazz units’ jurisdictional challenge
Two subsidiaries of Ireland-based Jazz Pharmaceuticals have failed in their bid to challenge the jurisdiction of the English High Court in a dispute with Tokyo-headquartered Otsuka Pharmaceutical over a cannabis sativa collaboration.
USITC to investigate botox imports
The US International Trade Commission has agreed to investigate imports of botulinum toxin products following a complaint that they infringe trade secrets.
Swiss scientist convicted for GSK trade secrets theft
A scientist working in Switzerland has been convicted of conspiring with his sister and others to steal trade secrets from GlaxoSmithKline for the benefit of their respective biopharmaceutical ventures.
